Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Metaxalone
Therapeutic Area : Neurology
Study Phase : Phase IV
Sponsor : Sun Valley Arthritis Center
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Metaxalone is a Other Small Molecule drug candidate, which is currently being evaluated in phase IV clinical studies for the treatment of Cognitive Dysfunction.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
April 24, 2024
Lead Product(s) : Metaxalone
Therapeutic Area : Neurology
Highest Development Status : Phase IV
Sponsor : Sun Valley Arthritis Center
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Metaxalone
Therapeutic Area : Undisclosed
Study Phase : Phase IV
Sponsor : ClinOhio Research Services, LLC
Deal Size : Inapplicable
Deal Type : Inapplicable
Study to Assess Drowsiness, Cognition, Fall Risk After Metaxalone 640 mg and Metaxalone 800 mg
Details : Metaxalone is a Other Small Molecule drug candidate, which is currently being evaluated in phase IV clinical studies for the treatment of undefined medical condition.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
April 04, 2024
Lead Product(s) : Metaxalone
Therapeutic Area : Undisclosed
Highest Development Status : Phase IV
Sponsor : ClinOhio Research Services, LLC
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Metaxalone
Therapeutic Area : Musculoskeletal
Study Phase : Phase IV
Sponsor : Illumination Health
Deal Size : Inapplicable
Deal Type : Inapplicable
Efficacy of M640 in Acute Lumbosacral Musculoskeletal Conditions.
Details : Metaxalone is a Other Small Molecule drug candidate, which is currently being evaluated in phase IV clinical studies for the treatment of Sciatica.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
December 05, 2023
Lead Product(s) : Metaxalone
Therapeutic Area : Musculoskeletal
Highest Development Status : Phase IV
Sponsor : Illumination Health
Deal Size : Inapplicable
Deal Type : Inapplicable